Stefan K.F. Schwabe

2017

In 2017, Stefan K.F. Schwabe earned a total compensation of $1.2M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$159,000
Option Awards$679,776
Salary$377,542
Other$31,606
Total$1,247,924

Schwabe received $679.8K in option awards, accounting for 54% of the total pay in 2017.

Schwabe also received $159K in non-equity incentive plan, $377.5K in salary and $31.6K in other compensation.

Rankings

In 2017, Stefan K.F. Schwabe's compensation ranked 7,917th out of 14,666 executives tracked by ExecPay. In other words, Schwabe earned more than 46.0% of executives.

ClassificationRankingPercentile
All
7,917
out of 14,666
46th
Division
Manufacturing
2,969
out of 5,772
49th
Major group
Chemicals And Allied Products
971
out of 2,075
53rd
Industry group
Drugs
757
out of 1,731
56th
Industry
Pharmaceutical Preparations
594
out of 1,333
55th
Source: SEC filing on April 27, 2018.

Schwabe's colleagues

We found five more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2017.

2017

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2017

Victor Vaughn

Supernus Pharmaceuticals

Senior Vice President of Sales and Marketing

2017

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2017

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

2017

Tami RN

Supernus Pharmaceuticals

Senior Vice President, Regulatory Affairs

News

In-depth

You may also like